 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Matrix Pharmaceutical, Inc.
 |
Matrix Pharmaceutical, Inc. |
 |
 |
 |
PROFILE |
 |
Matrix Pharmaceutical can't teach kung fu to Keanu Reeves, but it can knock out tumors. The development-stage firm makes cancer drug-delivery systems. Its IntraDose gel combines with chemotherapy agents and is directly injected into tumors and skin lesions to increase the drug's exposure time, maintain higher drug levels, and reduce toxicity. IntraDose is being developed as a possible treatment for colorectal and liver cancer and malignant melanoma; the product is waiting FDA approval as a therapy for head and neck cancer. Other products in trials include Tezacitabine, a chemical for leukemia and other hematologic cancers, and MPI 5020, a delivery system to enhance radiation treatments for breast cancer.
COMPETITION |
 |
Introgen Therapeutics, Inc. (INGN)
Onyx Pharmaceuticals, Inc. (ONXX)
SkyePharma Inc. (dossier)
DEALS |
 |
Deal: StorageWay Secures $42 Million
Date Announced: 06.21.01
Value of transaction (US $Mil): 42
Description: Storage service provider raises equity investment of $42 million. The financing will be used to build technology and expand services.
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 1.50
1-Yr. Sales Growth: 650.0%
Employees: 106
Revenue per employee: $14,150.94
KEY PEOPLE |
 |
Michael D. Casey
CEO
David W. Pritchard
CFO
CONTACT INFO |
 |
34700 Campus Dr.
Fremont, CA 94555
US
Phone: 510-742-9900
Fax: 510-742-8510
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |